LIGAND PHARMACEUTICALS INC reported 1 transaction at PELTHOS THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/3/2025ACC: 0000950170-25-093589
10% Owner
Since Jul 2025
+1.52M
Net shares
Net buyer
$15.00M
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.53M acquired · 15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.50M
Price / share
$10.00
Trade value
$15M
% of position
New position
7/1/2025
0.00→1.50M
Total
Net shares
+1.50M
Net value
$15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | C · Conversion | +1.50M | $10.00 | $15M | New position | 0.00 | 1.50M |
| Total | +1.50M | $15M | ||||||
Derivative Transactions2
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
1.50M shares
Shares
−15K
Strike price
10
Held after
3K
Exercisable
—
7/1/2025
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
3.13M shares
Shares
+31.28K
Strike price
10
Held after
34.28K
Exercisable
—
7/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock1.50M shares | 7/1/2025 | C · Conversion | −15K | 10 | — | 3K |
| Series A Convertible Preferred Stock Direct | Common Stock3.13M shares | 7/1/2025 | J · J | +31.28K | 10 | — | 34.28K |